RED EYE TRIPLE ACTION
Google image searchProduct monograph
Active ingredients
polyethylene glycol 400, 1 %/V/V
tetrahydrozoline hydrochloride, 0.05 %/W/V
DIN: 02518201
Dosage form(s): DROPS
Route(s) of administration: OPHTHALMIC
Schedule: OTC
Company: JOHNSON & JOHNSON INC
Date: 15-MAR-2022
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01G — DECONGESTANTS AND ANTIALLERGICS (ATC, ATC/DDD)
- S01GA — Sympathomimetics used as decongestants (ATC, ATC/DDD)
- S01GA52 — TETRYZOLINE, COMBINATIONS (ATC/DDD)
